fulvestrant has been researched along with angiotensin ii in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Hay, M; Pamidimukkala, J | 1 |
| Ikeda, K; Xu, JW; Yamori, Y | 1 |
| Hay, M; Lubahn, DB; Pamidimukkala, J; Xue, B | 1 |
| Huang, Y; Lu, LM; Shao, Y; Yao, T; Zhou, L | 1 |
| Dorn, GW; Liao, JK; Matter, CM; Ogita, H; Satoh, M; Takeshita, K; Wang, CY | 1 |
| Hay, M; Johnson, AK; Xue, B; Zhao, Y | 1 |
| Bland, KI; Chaudry, IH; Chen, J; Choudhry, MA; Hu, S; Yang, S | 1 |
| Beauregard, KG; Khalil, RA; Qiao, X; Raffetto, JD | 1 |
9 other study(ies) available for fulvestrant and angiotensin ii
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
17 beta-Estradiol inhibits angiotensin II activation of area postrema neurons.
Topics: Angiotensin II; Animals; Area Postrema; Calcium; Cells, Cultured; Cytosol; Electrophysiology; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Male; Neurons; Osmolar Concentration; Potassium Chloride; Rats | 2003 |
Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Anilides; Animals; Aorta, Thoracic; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hypertension; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Signal Transduction; Stroke; Superoxides; Tyrosine; Vasoconstrictor Agents | 2004 |
Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice.
Topics: Angiotensin II; Animals; Blood Pressure; Consciousness; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Ganglionic Blockers; Heart Rate; Hypertension; Injections, Intraventricular; Lateral Ventricles; Mice; Mice, Inbred C57BL; Mice, Knockout; Ovariectomy; Vasoconstrictor Agents | 2007 |
17beta-estradiol inhibits angiotensin II-induced collagen synthesis of cultured rat cardiac fibroblasts via modulating angiotensin II receptors.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cell Proliferation; Cells, Cultured; Collagen; Estradiol; Estrogen Antagonists; Fibroblasts; Fulvestrant; Heart; Imidazoles; Indicators and Reagents; Losartan; Myocardium; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |
Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.
Topics: Acetophenones; Angiotensin II; Animals; Apoptosis; Cardiomyopathy, Dilated; Cell Size; Cytosol; Dicarboxylic Acids; Drug Implants; Estradiol; Estrogen Receptor Modulators; Fulvestrant; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase Kinase 5; Membrane Proteins; Mice; Mice, Transgenic; Mitochondria; Myocytes, Cardiac; NADPH Oxidases; Neuropeptides; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Rats; Superoxides; Thioredoxin Reductase 1; Thioredoxin Reductase 2; Thioredoxin-Disulfide Reductase; Thioredoxins | 2007 |
Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Data Interpretation, Statistical; Estradiol; Estrogens; Fulvestrant; Hypertension; Injections, Intraventricular; Irbesartan; Male; Mice; Microscopy, Confocal; Oxidative Stress; Reactive Oxygen Species; Spin Labels; Subfornical Organ; Telemetry; Tetrazoles | 2008 |
Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor.
Topics: Angiotensin II; Animals; Cytokines; Down-Regulation; Estradiol; Fulvestrant; Hemorrhage; Inflammation; Male; Peroxidase; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2008 |
Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.
Topics: Acetylcholine; Angiotensin II; Animals; Calcium Signaling; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitriles; Phenols; Phenylephrine; Potassium Chloride; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Receptors, Estrogen; Receptors, G-Protein-Coupled; Sex Factors; Varicose Veins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Vena Cava, Inferior | 2010 |